This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2026 (epidemiological weeks 10-13). Click here to view PDF
Menu
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2026 (epidemiological weeks 10-13). Click here to view PDF
We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Click here to view PDF